Apexbio Technology LLC Clindamycin Phosphate 24729-96-2 50mg

Supplier:  Apexbio Technology LLC B170850

Clindamycin Phosphate (CAS 24729-96-2) is a prodrug derivative of clindamycin from the lincosamide antibiotic class It is designed to undergo enzymatic hydrolysis in vivo to release active clindamycin which inhibits bacterial protein synthesis by binding to ribosomal subunits exerting bacteriostatic effects Clindamycin Phosphate exhibits no direct antibacterial activity in vitro but demonstrates bacteriostatic activity upon hydrolysis to clindamycin Reported IC50 values of clindamycin against sensitive bacterial strains are typically in the low micromolar concentration range Based on these pharmacological properties Clindamycin Phosphate holds research potential in studies focused on microbial pathogens associated with skin infections acne and bacterial vaginosis It has also been assessed in combination strategies such as coupling with platelet-rich fibrin (PRF) to enhance antibacterial capacity without observable cytotoxicity

Catalog No. 50-000-94554